These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35394514)

  • 1. Effect of Plasma and Blood Donations on Levels of Perfluoroalkyl and Polyfluoroalkyl Substances in Firefighters in Australia: A Randomized Clinical Trial.
    Gasiorowski R; Forbes MK; Silver G; Krastev Y; Hamdorf B; Lewis B; Tisbury M; Cole-Sinclair M; Lanphear BP; Klein RA; Holmes N; Taylor MP
    JAMA Netw Open; 2022 Apr; 5(4):e226257. PubMed ID: 35394514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study protocol for a randomised controlled trial examining the effect of blood and plasma donation on serum perfluoroalkyl and polyfluoroalkyl substance (PFAS) levels in firefighters.
    Silver G; Krastev Y; Forbes MK; Hamdorf B; Lewis B; Tisbury M; Taylor MP; Gasiorowski R
    BMJ Open; 2021 May; 11(5):e044833. PubMed ID: 33963058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal decline in serum PFAS concentrations among metropolitan firefighters: Longitudinal study on post-exposure changes following PFAS foam cessation.
    Mesfin Tefera Y; Gaskin S; Mitchell K; Springer D; Mills S
    Environ Int; 2023 Sep; 179():108167. PubMed ID: 37651929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentration trends and apparent half-lives of per- and polyfluoroalkyl substances (PFAS) in Australian firefighters.
    Nilsson S; Smurthwaite K; Aylward LL; Kay M; Toms LM; King L; Marrington S; Barnes C; Kirk MD; Mueller JF; Bräunig J
    Int J Hyg Environ Health; 2022 Sep; 246():114040. PubMed ID: 36162311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
    Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
    Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomonitoring of per- and polyfluoroalkyl substances (PFAS) exposure in firefighters: Study design and lessons learned from stakeholder and participant engagement.
    Nilsson S; Smurthwaite K; Aylward LL; Kay M; Toms LM; King L; Marrington S; Hobson P; Barnes C; Rotander A; Kirk MD; Mueller JF; Braeunig J
    Int J Hyg Environ Health; 2022 May; 242():113966. PubMed ID: 35398800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water.
    Li Y; Barregard L; Xu Y; Scott K; Pineda D; Lindh CH; Jakobsson K; Fletcher T
    Environ Health; 2020 Mar; 19(1):33. PubMed ID: 32169067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum per- and polyfluoroalkyl substance concentrations in four municipal US fire departments.
    Burgess JL; Fisher JM; Nematollahi A; Jung AM; Calkins MM; Graber JM; Grant CC; Beitel SC; Littau SR; Gulotta JJ; Wallentine DD; Hughes RJ; Popp C; Calafat AM; Botelho JC; Coleman AD; Schaefer-Solle N; Louzado-Feliciano P; Oduwole SO; Caban-Martinez AJ
    Am J Ind Med; 2023 May; 66(5):411-423. PubMed ID: 35864570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between perfluoroalkyl substances and lipid profile in exposed pregnant women in the Veneto region, Italy.
    Dalla Zuanna T; Savitz DA; Barbieri G; Pitter G; Zare Jeddi M; Daprà F; Fabricio ASC; Russo F; Fletcher T; Canova C
    Ecotoxicol Environ Saf; 2021 Feb; 209():111805. PubMed ID: 33360787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of serum half-lives for linear and branched perfluoroalkyl substances after long-term high exposure-A study in Ronneby, Sweden.
    Li Y; Andersson A; Xu Y; Pineda D; Nilsson CA; Lindh CH; Jakobsson K; Fletcher T
    Environ Int; 2022 May; 163():107198. PubMed ID: 35447437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances during pregnancy and anogenital distance in male infants.
    Tian Y; Liang H; Miao M; Yang F; Ji H; Cao W; Liu X; Zhang X; Chen A; Xiao H; Hu H; Yuan W
    Hum Reprod; 2019 Jul; 34(7):1356-1368. PubMed ID: 31242507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of contamination sources for poly- and perfluoroalkyl substances (PFASs) on Svalbard (Norwegian Arctic).
    Skaar JS; Ræder EM; Lyche JL; Ahrens L; Kallenborn R
    Environ Sci Pollut Res Int; 2019 Mar; 26(8):7356-7363. PubMed ID: 29754295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluoroalkyl substances exposure in firefighters: Sources and implications.
    Rosenfeld PE; Spaeth KR; Remy LL; Byers V; Muerth SA; Hallman RC; Summers-Evans J; Barker S
    Environ Res; 2023 Mar; 220():115164. PubMed ID: 36584840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of legacy and emerging per- and polyfluoroalkyl substances in the Anniston Community Health Surveys (ACHS I and ACHS II).
    Petriello MC; Mottaleb MA; Serio TC; Balyan B; Cave MC; Pavuk M; Birnbaum LS; Morris AJ
    Environ Int; 2022 Jan; 158():106907. PubMed ID: 34763231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
    Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019.
    Göckener B; Weber T; Rüdel H; Bücking M; Kolossa-Gehring M
    Environ Int; 2020 Dec; 145():106123. PubMed ID: 32949877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011.
    Toms LM; Thompson J; Rotander A; Hobson P; Calafat AM; Kato K; Ye X; Broomhall S; Harden F; Mueller JF
    Environ Int; 2014 Oct; 71():74-80. PubMed ID: 24980755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate concentrations and serum perfluoroalkyl and polyfluoroalkyl substance concentrations in adolescents and adults in the USA (National Health and Nutrition Examination Study 2003-16): an observational study.
    Zhang Y; Mustieles V; Wang YX; Sun Y; Agudelo J; Bibi Z; Torres N; Oulhote Y; Slitt A; Messerlian C
    Lancet Planet Health; 2023 Jun; 7(6):e449-e458. PubMed ID: 37286242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing exposures to per- and polyfluoroalkyl substances in two populations of Great Lakes Basin fish consumers in Western New York State.
    Liu M; Nordstrom M; Forand S; Lewis-Michl E; Wattigney WA; Kannan K; Wang W; Irvin-Barnwell E; Hwang SA
    Int J Hyg Environ Health; 2022 Mar; 240():113902. PubMed ID: 34915281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of exposure to multiple perfluoroalkyl and polyfluoroalkyl substances and glucose metabolism in National Health and Nutrition Examination Survey 2017-2018.
    Tian Q; Yang Y; An Q; Li Y; Wang Q; Zhang P; Zhang Y; Zhang Y; Mu L; Lei L
    Front Public Health; 2024; 12():1370971. PubMed ID: 38633237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.